Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Nineteen human breast carcinoma cell lines have been established as continuous cultures during the past 6 years in our laboratory. This preliminary report is designed to list the lines by their designated code numbers (MDA-MB) and present a brief summary of their morphological, cytogenetic and biochemical characteristics. Sixteen of our lines were obtained from pleural effusions, two from brain metastases, and one from pericardial fluid. All lines have been shown to be distinct entities and are uncontaminated by HeLa cells or each other. A lq marker chromosome is present in all but one of the lines examined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDA‐MB‐435 was reported to be established at the MD Anderson Hospital and Tumor Institute from a 31‐year‐old female patient with metastatic breast carcinoma and were placed into culture on January 23, 1976.14, 29”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [14]
In the citing paper
“The M14 vials were both dated December 2, 1975, 7 weeks before MDA‐MB‐435 cells were first placed into culture (Fig. 1 a,14).”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [14]
Citations
Cites
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Self-citationAbsence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2
Fogh, J., Wright, W. C., & Loveless, J. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.209 · Cited by 663
Hackett, A. J., Smith, H. S., Springer, E. L., Owens, R. B., Nelson-Rees, W. A., Riggs, J. L., & Gardner, M. B. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.6.1795 · Cited by 309
Cultivation of Human Breast Carcinomas 2
(1958) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/21.6.1131 · Cited by 276
Human breast carcinomas: marker chromosomes involving 1q in seven cases
Cruciger, J., Pathak, S., & Cailleau, R. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000130716 · Cited by 125
Self-citationEstablishment and Characteristics of Cell Strains From Some Epithelial Tumors of Human Origin
(1963) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/31.5.1173 · Cited by 92
Young, R. K., Cailleau, R., Mackay, B., & Reeves, W. J. (1974) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02616069 · Cited by 85
Self-citationMicroscopic demonstration of mycoplasma contamination in cell cultures and cell culture media
Chen, T. R. (1976) · Methods in Cell Science · doi:10.1007/bf00917008 · Cited by 75
Tissue culture studies on pleural effusions from breast carcinoma patients.
Cailleau, R., Mackay, B., Young, R. K., & Reeves, W. J. (1974) · PubMed · Cited by 66
Self-citation(1979) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/62.2.263 · Cited by 60
Self-citation
Research works printed but not linked: 3
- Lasfargues, E. Y., and L. Ozzello. 1958. Cultivation of human breast carcinoma. J. Nat. Cancer Inst. 21: 1131–1147.
- Pathak, S., M. J. Siciliano, R. Cailleau, C. L. Wiseman, and T. C. Hsu. A human breast adenocarcinoma with chromosome and isozyme markers similar to those of the HeLa line. J. Nat. Cancer Inst., in press.
- Cruciger, Q., S. Pathak, P. Barker, R. Cailleau, N. Eckles, and G. Blumenschein. 1978. Consistent translocation of lq chromosome in metastatic breast cancer tissue and cell lines. Clinical correlations (abstr.). Clin. Res. 26: 433.
Cited by
Items 201–300 of 679
Mei, J., Tian, H., Huang, H.-S., Hsu, C., Liou, Y., Wu, N., Zhang, W., & Chu, T. (2021) · Cell Proliferation · doi:10.1111/cpr.13029 · Cited by 59
Donnelly, C., Olsen, A., Lewis, L. D., Eisenberg, B. L., Eastman, A. R., & Kinlaw, W. B. (2009) · Nutrition and Cancer · doi:10.1080/01635580802348666 · Cited by 50
Bussard, K. M., & Smith, G. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049221 · Cited by 48
Metastatic breast cancer cells colonize and degrade three-dimensional osteoblastic tissue in vitro
Ravi, D., Krishnan, V., Shuman, L. A., Mastro, A. M., & Vogler, E. A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9185-z · Cited by 49
Redzic, J. S., Kendrick, A. A., Bahmed, K., Dahl, K. D., Pearson, C. G., Robinson, W. A., Robinson, S. E., Graner, M. W., & Eisenmesser, E. Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071225 · Cited by 50
Zalfa, F., Panasiti, V., Carotti, S., Zingariello, M., Perrone, G., Sancillo, L., Pacini, L., Luciani, F., Roberti, V., D’Amico, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.521 · Cited by 52
Deep learning predicts chromosomal instability from histopathology images
Xu, Z., Verma, A., Naveed, U., Bakhoum, S. F., Khosravi, P., & Elemento, O. (2021) · iScience · doi:10.1016/j.isci.2021.102394 · Cited by 48
Hartsuiker, L., Zeijen, N. J. L., Terstappen, L. W. M. M., & Otto, C. (2010) · The Analyst · doi:10.1039/c0an00524j · Cited by 47
Westbrook, J. A., Wood, S. L., Cairns, D. A., McMahon, K., Gahlaut, R., Thygesen, H., Shires, M., Roberts, S., Marshall, H., Oliva, M. R., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5197 · Cited by 47
“The MDA-MB-231 cell line is regarded as the ‘gold standard’ for this type of research as it was derived from a pleural effusion of a breast cancer patient with widespread tumour metastasis, many years after resection of the primary tumour [23].”
BackgroundGrünewald, K., Haun, M., Fiegl, M., Urbanek, M., Müller‐Holzner, E., Massoner, A., Riha, K., Propst, A., Marth, C., & Gastl, G. A. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000027840.16064.8a · Cited by 47
Bjorge, J. D., Pang, A., Funnell, M., Chen, K. Y., Diaz, R., Magliocco, A. M., & Fujita, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019309 · Cited by 46
Tu, Y., Kaipparettu, B. A., Ma, Y., & Wong, L.-J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.015 · Cited by 49
Locard‐Paulet, M., Lim, L., Veluscek, G., McMahon, K. M., Sinclair, J., van Weverwijk, A., Worboys, J. D., Yuan, Y., Isacke, C. M., & Jørgensen, C. (2016) · Science Signaling · doi:10.1126/scisignal.aac5820 · Cited by 47
New generation breast cancer cell lines developed from patient-derived xenografts
Finlay-Schultz, J., Jacobsen, B. M., Riley, D., Vinod-Paul, K., Turner, S. A., Ferreira‐Gonzalez, A., Harrell, J. C., Kabos, P., & Sartorius, C. A. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01300-y · Cited by 46
Glynn, S. A., Gammell, P., Heenan, M., O'Connor, R. A., Liang, Y., Keenan, J., & CLYNES, M. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602221 · Cited by 46
A Mathematical Model of Drug Transport in Human Breast Cancer
Lankelma, J., Luque, R. F., Dekker, H., Schinkel, W. M. M., & Pinedo, H. M. (2000) · Microvascular Research · doi:10.1006/mvre.1999.2218 · Cited by 47
Roles of osteonectin in the migration of breast cancer cells into bone
McKnight, D., Sosnoski, D. M., Koblinski, J. E., & Gay, C. V. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20644 · Cited by 46
Robertson, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.11.009 · Cited by 45
Tuck (2009) · International Journal of Oncology · doi:10.3892/ijo_00000340 · Cited by 45
Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model
Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M., & Steve Goodison, B. (2007) · PROTEOMICS · doi:10.1002/pmic.200600272 · Cited by 45
Sikora, M. J., Jankowitz, R. C., Dabbs, D. J., & Oesterreich, S. (2012) · Steroids · doi:10.1016/j.steroids.2012.11.002 · Cited by 44
Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer
Xu, L., Kwon, Y.-J., Frolova, N., Steg, A. D., Yuan, K., Johnson, M. R., Grizzle, W. E., Desmond, R. A., & Frost, A. R. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0617-5 · Cited by 43
Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells
Pio, G. M., Xia, Y., Piaseczny, M. M., Chu, J. E., & Allan, A. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177640 · Cited by 43
Bajo, A. M., Schally, A. V., Krupa, M., Hébert, F., Groot, K., & Szepesházi, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052715299 · Cited by 43
Cytotoxic Activities against Breast Cancer Cells of Local Justicia gendarussa Crude Extracts
Ayob, Z., Bohari, S. P. M., Samad, A. A., & Jamil, S. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/732980 · Cited by 42
Chu, J. E., Xia, Y., Chin-Yee, B. H., Goodale, D. B., Croker, A. K., & Allan, A. L. (2014) · Neoplasia · doi:10.1593/neo.132076 · Cited by 44
Terefinko, D., Dzimitrowicz, A., Bielawska‐Pohl, A., Klimczak, A., Pohl, P., & Jamróz, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083855 · Cited by 46
Amemiya, Y., Yang, W., Benatar, T., Nofech‐Mozes, S., Yee, A., Kahn, H. K., Holloway, C. M. B., & Seth, A. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0921-0 · Cited by 45
Zhang, S., Wu, T.-C., Peng, X., Liu, J., Liu, F., Wu, S., Liu, S., Dong, Y., Xie, S., & Ma, S. (2017) · Cancer Management and Research · doi:10.2147/cmar.s149801 · Cited by 43
Short-Term Microgravity Influences Cell Adhesion in Human Breast Cancer Cells
Nassef, M. Z., Kopp, S., Melnik, D., Corydon, T. J., Sahana, J., Krüger, M., Wehland, M., Bauer, T. J., Liemersdorf, C., Hemmersbach, R., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225730 · Cited by 40
Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations
Hollestelle, A., Elstrodt, F., Timmermans, M. A. M., Sieuwerts, A. M., Klijn, J. G. M., Foekens, J. A., den Bakker, M. A., & Schutte, M. E. M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0545-4 · Cited by 46
Targeting of VEGF‐dependent transendothelial migration of cancer cells by bevacizumab
Prager, G. W., Lackner, E., Krauth, M., Unseld, M., Poettler, M., Laffer, S., Cerny‐Reiterer, S., Lamm, W. W., Kornek, G. V., Binder, B. R., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.01.002 · Cited by 40
Zhang, C., Yan, Z., Arango, M. E., Painter, C. L., & Anderes, K. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0897 · Cited by 41
Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice
Schackert, G., Price, J. E., Bucana, C. D., & Fidler, I. J. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440524 · Cited by 40
Modulation of galactoside-binding lectins in tumor cells by differentiation-inducing agents
Lotan, R., Lotan, D., & Carralero, D. (1989) · Cancer Letters · doi:10.1016/0304-3835(89)90046-3 · Cited by 40
Paul, A., Danley, M., Saha, B., Tawfik, O. W., & Paul, S. (2015) · Scientific Reports · doi:10.1038/srep12520 · Cited by 49
Green, B. J., Marazzini, M., Hershey, B. J., Fardin, A., Li, Q., Wang, Z., Giangreco, G., Pisati, F., Marchesi, S., Disanza, A., et al. (2022) · Small · doi:10.1002/smll.202106097 · Cited by 43
Gomena, J., Vári, B., Oláh-Szabó, R., Biri‐Kovács, B., Bősze, S. E., Borbély, A., Soós, Á., Ranđelović, I., Tóvári, J., & Mező, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043400 · Cited by 45
Donato, M. D., Galasso, G., Giovannelli, P., Sinisi, A. A., Migliaccio, A., & Castoria, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676568 · Cited by 40
Harada (2010) · International Journal of Oncology · doi:10.3892/ijo_00000711 · Cited by 37
Gromova, I., Gromov, P., Honma, N., Kumar, S., Rimm, D. L., Talman, M., Wielenga, V. T., & Moreira, J. M. A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.003 · Cited by 40
Tanaka, Y., Hirata, M., Shinonome, S., Torii, M., Nezasa, K., & Tanaka, H. (2018) · Scientific Reports · doi:10.1038/s41598-017-18702-2 · Cited by 37
Galluzzi, M., Schulte, C., Milani, P., & Podestà, A. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b01554 · Cited by 43
MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity
Capelôa, T., Krzystyniak, J., d’Hose, D., Rodriguez, A. C., Payen, V. L., Zampieri, L. X., de Velde, J. A. V., Benyahia, Z., Pranzini, E., Vazeille, T., et al. (2022) · Cancers · doi:10.3390/cancers14061516 · Cited by 36
Boimel, P., Cruz, C. D., & Segall, J. (2011) · Genomics · doi:10.1016/j.ygeno.2011.05.011 · Cited by 40
Lund, R. R., Leth‐Larsen, R., Caterino, T. D., Terp, M. G., Nissen, J., Lænkholm, A., Jensen, O. N., & Ditzel, H. J. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.050385 · Cited by 36
Huang, L., Lin, C., Qiu, J.-Z., Lin, C., Hsu, K., Tam, K., Lee, J.-Y., Yang, J., & Lee, C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00336 · Cited by 39
Park, H. J., & Helfman, D. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56276-3 · Cited by 46
Sone, S., Lopez‐Berestein, G., & Fidler, I. J. (1986) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199855 · Cited by 37
Schmidt, C. M., Settle, S. L., Keene, J. L., Westlin, W., Nickols, G. A., & Griggs, D. W. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006719800907 · Cited by 36
Andriani, F., Nan, B., Yu, J., Li, X., Weigel, N. L., McPhaul, M. J., Kasper, S. F., Kagawa, S., Fang, B., Matusik, R. J., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1314 · Cited by 41
Cytogenetic analysis in human breast tumors
Pathak, S. (1980) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(80)90025-4 · Cited by 36
Expression of melanocyte-related genes in human breast cancer and its implications
Montel, V., Suzuki, M., Galloy, C., Mose, E. S., & Tarin, D. (2009) · Differentiation · doi:10.1016/j.diff.2009.07.007 · Cited by 35
Yu, K., Shao, Q., Ashkenazi, S., Bischof, J. C., & He, B. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2560146 · Cited by 38
Expression of a SOX1 overlapping transcript in neural differentiation and cancer models
Ahmad, A., Strohbuecker, S., Tufarelli, C., & Sottile, V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2580-3 · Cited by 36
FGF13 promotes metastasis of triple‐negative breast cancer
Johnstone, C. N., Pattison, A., Harrison, P. F., Powell, D., Lock, P., Ernst, M., Anderson, R. L., & Beilharz, T. H. (2020) · International Journal of Cancer · doi:10.1002/ijc.32874 · Cited by 39
Ruthenium(II) Sulfoxide−Maltolato and −Nitroimidazole Complexes: Synthesis and MTT Assay
Wu, A., Kennedy, D. C., Patrick, B. O., & James, B. R. (2003) · Inorganic Chemistry · doi:10.1021/ic030119j · Cited by 35
Phytoestrogens as natural prodrugs in cancer prevention: dietary flavonoids
Arroo, R., Androutsopoulos, V. P., Beresford, K. J. M., Ruparelia, K. C., Surichan, S., Wilsher, N. E., & Potter, G. A. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9128-6 · Cited by 39
Tissue engineered tumor models
Ingram, M., Techy, G. B., Ward, B., Imam, S. A., Atkinson, R., Ho, H., & Cr, T. (2010) · Biotechnic & Histochemistry · doi:10.3109/10520295.2010.483655 · Cited by 36
Engel, J. B., Schally, A. V., Halmos, G., Baker, B., Nagy, A., & Keller, G. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01022 · Cited by 35
Shashni, B., Horiguchi, Y., Kurosu, K., Furusho, H., & Nagasaki, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.038 · Cited by 35
Niggemann, B., Maaser, K., Lü, H., Kroczek, R., Zänker, K. S., & Friedl, P. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00328-5 · Cited by 35
Tang, G., Galluzzi, M., Zhang, B., Shen, Y., & Stadler, F. J. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02211 · Cited by 34
Stasenko, M., Smith, E. S., Yeku, O., Park, K. J., Laster, I., Lee, K., Walderich, S. J., Spriggs, E. L., Rueda, B. R., Weigelt, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82686-3 · Cited by 33
Kansra, S., Stoll, S. W., Johnson, J. L., & Elder, J. T. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004689 · Cited by 36
Proteomic phenotyping: metastatic and invasive breast cancer
Hathout, Y., Gehrmann, M. L., Chertov, A. O., & Fenselau, C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.01.019 · Cited by 34
Novel tertiary sulfonamides as potent anti-cancer agents
Okolotowicz, K. J., Dwyer, M., Ryan, D., Cheng, J., Cashman, E. A., Moore, S., Mercola, M. A., & Cashman, J. R. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.042 · Cited by 33
Differential regulation of oestrogen receptor β isoforms by 5′ untranslated regions in cancer
Smith, L., Millican-Slater, R. A., Hanby, A. M., Shaaban, A. M., Verghese, E. T., Peter, M. B., Pollock, S., Satheesha, S., Szynkiewicz, M., Speirs, V., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00867.x · Cited by 38
Recent advances in breast cancer cell line research
Sharma, M. P., Shukla, S., & Misra, G. (2024) · International Journal of Cancer · doi:10.1002/ijc.34849 · Cited by 38
Carbohydrates in Drug Design and Discovery
(2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739993 · Cited by 32
Lee, J., Kim, S., Na, H., & Min, D. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600328 · Cited by 34
Suzuki, M., Mose, E. S., Galloy, C., & Tarin, D. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070232 · Cited by 32
Skildum, A. J., Dornfeld, K. J., & Wallace, K. B. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1268-2 · Cited by 32
Joy, A. P., Ayre, D. C., Chute, I. C., Beauregard, A., Wajnberg, G., Ghosh, A., Lewis, S. M., Ouellette, R. J., & Barnett, D. A. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1438727 · Cited by 36
Wang, Q., Karvelsson, S. T., Kotronoulas, A., Guðjónsson, Þ., Halldórsson, S., & Rolfsson, Ó. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100185 · Cited by 34
MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice
Capelôa, T., Krzystyniak, J., Rodriguez, A. C., Payen, V. L., Zampieri, L. X., Pranzini, E., Derouane, F., Vazeille, T., Bouzin, C., Duhoux, F. P., et al. (2022) · Cancers · doi:10.3390/cancers14061488 · Cited by 32
Hadad, S. M., Appleyard, V. C. L., & Thompson, A. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0016-3 · Cited by 31
Cody, J. J., Scaturro, P., Cantor, A. B., Gillespie, G. Y., Parker, J. N., & Markert, J. M. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/628697 · Cited by 35
Antineoplastic Activity of Solidago virgaurea on Prostatic Tumor Cells in an SCID Mouse Model
Gross, S. C., Goodarzi, G., Watabe, M., Bandyopadhyay, S., Pai, S. K., & Watabe, K. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc431_9 · Cited by 31
Price, J. E., Bell, C. W., & Frost, P. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450532 · Cited by 31
Zhong, Z., Rosenow, M. A., Xiao, N., & Spetzler, D. B. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1458574 · Cited by 31
Experimental Models as Refined Translational Tools for Breast Cancer Research
Costa, E., Ferreira-Gonçalves, T., Chasqueira, G., Cabrita, A., Figueiredo, I. V., & Reis, C. P. (2020) · Scientia Pharmaceutica · doi:10.3390/scipharm88030032 · Cited by 37
Baranyai, Z., Biri‐Kovács, B., Krátký, M., Szeder, B., Debreczeni, M. L., Budai, J., Kovács, B., Horváth, L. B., Pári, E., Németh, Z., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01399 · Cited by 37
Vignoli, A., Marchetti, M., Russo, L., Cantalino, E., Diani, E., Bonacina, G., & Falanga, A. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.543217 · Cited by 30
Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines
Kelner, M. J., McMorris, T. C., Montoya, M. A., Estes, L. A., Uglik, S. F., Rutherford, M., Samson, K. M., Bagnell, R. D., & Taetle, R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050972 · Cited by 30
Pasqualini, J. R., & Nguyen, B. ‐. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01980971 · Cited by 30
Yao, H., Veine, D. M., Fay, K. S., Staszewski, E. D., Zeng, Z.-Z., & Livant, D. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0826-y · Cited by 29
Gu, Y., Helenius, M., Väänänen, K., Bulanova, D. R., Saarela, J., Соколенко, А. П., Martens, J. W. M., Имянитов, Е. Н., & Kuznetsov, S. G. (2016) · Scientific Reports · doi:10.1038/srep28217 · Cited by 31
Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy
Knobf, M. T. (1990) · Cancer · doi:10.1002/1097-0142(19900915)66:14+<1392::aid-cncr2820661415>3.0.co;2-t · Cited by 48
Antitumor activity of treosulfan against human breast carcinomas
K�pf-Maier, P., & Sa�, G. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685095 · Cited by 29
Jordan, K. R., Hall, J., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01363-x · Cited by 31
Howard, G. R., Jost, T. A., Yankeelov, T. E., & Brock, A. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009104 · Cited by 31
Wu, A., Mazumder, A., Martuza, R. L., Liu, X., Thein, M. S., Meehan, K. R., & Rabkin, S. D. (2001) · PubMed · Cited by 28
The Role of Fluid Shear and Metastatic Potential in Breast Cancer Cell Migration
Riehl, B. D., Kim, E., Lee, J. S., Duan, B., Yang, R., Donahue, H. J., & Lim, J. Y. (2020) · Journal of Biomechanical Engineering · doi:10.1115/1.4047076 · Cited by 29
Tian, J., Wang, V., Wang, N., Khadang, B., Boudreault, J., Bakdounes, K., Ali, S., & Lebrun, J. J. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01401-2 · Cited by 28
Nielsen, K. V., & Briand, P. (1989) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(89)90236-7 · Cited by 27
Diversity of Matriptase Expression Level and Function in Breast Cancer
Welman, A., Sproul, D., Mullen, P., Muir, M., Kinnaird, A., Harrison, D. J., Faratian, D., Brunton, V. G., & Frame, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034182 · Cited by 26
Bussard, K. M., Okita, N., Sharkey, N. A., Neuberger, T., WEBB, A. G., & Mastro, A. M. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9330-3 · Cited by 26
Tumor–Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic ImplicationsPreprint
Zheng, H., Li, W., & Kang, Y. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030775 · Cited by 25
Raatschen, H., Fu, Y., Brasch, R. C., Pietsch, H., Shames, D. M., & Yeh, B. M. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e31819f1b60 · Cited by 25
Metadata
- Authors
- Cailleau, R., Olivé, M., & Cruciger, Q. V. J.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- In Vitro
- Published
- 1978-11
- Volume
- 14
- Issue
- 11
- Pages
- 911-915
- ISSN
- 1054-5476 (ISSN-L)
- 0073-5655
- 1475-2689
- OpenAlex
- W1966542709
- Cited by
- 679
- References
- 13
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 29 · 2023: 27 · 2022: 17 · 2021: 40 · 2020: 22 · 2019: 23 · 2018: 27 · 2017: 22 · 2016: 21 · 2015: 28 · 2014: 23 · 2013: 21 · 2012: 23
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- In Vitro Cellular & Developmental Biology - Plant (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer cell lines, metastatic breast cancer, pleural effusion, brain metastases, pericardial fluid, cytogenetics, cell morphology, biochemical characterization, cell line contamination
- MeSH terms
- Adult, Animals, Brain Neoplasms, Breast Neoplasms, Cell Line, Epithelium, Female, Glucosephosphate Dehydrogenase, Humans, Isoenzymes, Mice, Nude, Middle Aged, Neoplasm Metastasis, Neoplasm Transplantation, Pericardial Effusion, Pleural Effusion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.